Similar articles

• Long-term trends in adherence to antiretroviral therapy from start of HAART.

  Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN. Cambiano V, et al. AIDS. 2010 May 15;24(8):1153-62. doi: 10.1097/QAD.0b013e32833847af. AIDS. 2010. PMID: 20299959
• [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].

  Wepner U. Wepner U. MMW Fortschr Med. 2009 Apr 30;151(18):80-1. MMW Fortschr Med. 2009. PMID: 19769085 German. No abstract available.
• Parallel evolutions of the growth rate of newly diagnosed HIV cases and the proportion of potentially infective patients in Cayenne French Guiana: should HAART be used to curb the epidemic?

  Nacher M, Vantilcke V, Huber F, El Guedj M, Vaz T, Magnien C, Djossou F, Mahamat A, Dabis F, Couppié P. Nacher M, et al. Public Health. 2009 Aug;123(8):573-4. doi: 10.1016/j.puhe.2009.06.007. Epub 2009 Aug 18. Public Health. 2009. PMID: 19692100 No abstract available.
• Issues in antiretroviral therapy: when to start?

  Boyle BA. Boyle BA. AIDS Read. 2001 Feb;11(2):66-70. AIDS Read. 2001. PMID: 11279874 Review. No abstract available.
• The public health implications of HIV therapy.

  Ritsema TS. Ritsema TS. JAAPA. 2002 Apr;15(4):29-30, 33-4, 39. JAAPA. 2002. PMID: 12012585 Review. No abstract available.